• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.26 0.11
(0.12%)
EUR-INR
110.12 0.41
(0.38%)
GBP-INR
129.49 0.88
(0.69%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
543349
INE00FF01025
203.7819344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACUTAAS
80.09
29328.69
EPS(TTM)
Face Value()
Div & Yield %
44.73
5
0.07
 

almondz global securities ltd
B L Kashyap bags Rs 300-cr order from CRC Greens for Greater Noida housing project
Feb 18,2026

In a regulatory filing, the company said the order involves construction and supervision of civil structural works for the residential project. The contract is domestic in nature and is to be executed over an approximate period of 42 months.

The total contract value stands at Rs 300 crore, excluding GST.

The company clarified that neither the promoter nor the promoter group companies have any interest in the awarding entity. The contract does not fall under related party transactions.

BL Kashyap & Sons is one of India’s most respected construction and infrastructure development company with a pan India presence.

The company's consolidated net profit zoomed 965.8% to Rs 11.83 crore on a 33.9% increase in revenue from operations to Rs 323.87 crore in Q3 FY26 over Q3 FY25.

Shares of B. L. Kashyap and Sons rose 0.30% to end at Rs 50.08 on the BSE.